Eli Diaz thought Wegovy was a miracle as she tried to get back to her pre-baby weight. But she had to come off it and put on more weight than she’d lost. Experts say she is not alone.

An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen yet ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months.

Wegovy is FDA-approved for weight loss; Ozempic and Mounjaro are not. These drugs were originally prescribed to patients with Type 2 diabetes as they produce insulin and lower blood sugar.

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently approved medicine, Zepbound, but didn’t cleanly surpass it in late ...

People taking the drug and similar medications will hit an inevitable, and necessary, plateau. Here’s why. By Dani Blum Kimmy Meinecke blamed herself when she stopped losing weight. For two ...

The more weight Ms. Acevedo, a longtime athlete, gained, the harder it was to move. Since she started on a weight-loss drug, she’s lost 30 pounds, and her blood sugar levels have fallen.

My weight loss has slowed — depending on the day, I’m down a pound or two this year — and that’s fine. The critical question is whether, for the first time in my life, I will be able to ...

For the first time, Medicare will allow coverage of one of the new blockbuster weight-loss drugs for enrollees in Part D plans. The plans may now cover Wegovy when prescribed to prevent heart ...